Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEP1B | Q16820 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CASP6 | P55212 | 1/20 | 0.36 |
| ▸ | ELAVL1 | Q15717 | 1/20 | 0.36 |
| ▸ | MYC | P01106 | 1/20 | 0.36 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.36 |
| ▸ | MPL | P40238 | 1/20 | 0.35 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.34 |
| ▸ | SNCA | P37840 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14991279 | 0.85 | AMY1A (0.44) | GAAHSD17B10KMT2AMEP1BMEN1 | |
| SCHEMBL30236538 | 0.85 | RAPGEF4 (0.44) | GAAHSD17B10KMT2AMEP1BMEN1 | |
| SCHEMBL30716894 | 0.85 | AMY1A (0.44) | GAAHSD17B10KMT2AMEP1BMEN1 | |
| SCHEMBL30823619 | 0.85 | GAA (0.41) | GAAHSD17B10KMT2AMEP1BMEN1 | |
| SCHEMBL1180196 | 0.85 | GAA (0.41) | GAAHSD17B10KMT2AMEP1BMEN1 | |
| SCHEMBL1607815 | 0.85 | RAPGEF4 (0.44) | GAAHSD17B10KMT2AMEP1BMEN1 | |
| SCHEMBL1806437 | 0.83 | MPL (0.38) | GAAHSD17B10KMT2AMEP1BMEN1 | |
| Water SCHEMBL27145442 | 0.83 | RAPGEF4 (0.43) | GAAHSD17B10KMT2AMEP1BMEN1 | |
| SCHEMBL1806434 | 0.83 | ALDH1A1 (0.37) | GAAHSD17B10KMT2AMEP1BMEN1 | |
| SCHEMBL5718625 | 0.81 | GAA (0.39) | GAAHSD17B10KMT2AMEP1BMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021110306-A1 | MULTI-TONE HAIR DYEING METHOD IN THREE STEPS | HENKEL AG & CO. KGAA (DE) | 2021-06-10 | — | — | WO | disclosed |
| US-20150290127-A1 | TRANEXAMIC ACID FORMULATIONS | AMRING PHARMACEUTICALS, INC. | 2015-10-15 | — | — | US | disclosed |
| US-9060939-B2 | Tranexamic acid formulations | FERRING B.V. (NL) | 2015-06-23 | — | — | US | disclosed |
| US-8968777-B2 | Tranexamic acid formulations with reduced adverse effects | FERRING B.V. (NL) | 2015-03-03 | — | — | US | disclosed |
| US-8957113-B2 | Tranexamic acid formulations | FERRING B.V. (NL) | 2015-02-17 | — | — | US | disclosed |
| US-8809394-B2 | Tranexamic acid formulations | FERRING B.V. (NL) | 2014-08-19 | — | — | US | disclosed |
| US-8791160-B2 | Tranexamic acid formulations | FERRING B.V. (NL) | 2014-07-29 | — | — | US | disclosed |
| US-8487005-B2 | Tranexamic acid formulations | FERRING B.V. (NL) | 2013-07-16 | — | — | US | disclosed |
| US-20130096198-A1 | Tranexamic Acid Formulations | FERRING B.V. (NL) | 2013-04-18 | — | — | US | disclosed |
| US-20130018100-A1 | Tranexamic Acid Formulations | FERRING B.V. (NL) | 2013-01-17 | — | — | US | disclosed |
| US-7473280-B2 | Coloring agent compositions and methods of treating keratin fibers therewith | HENKEL KGAA (DE) | 2009-01-06 | — | — | US | disclosed |
| US-20080280981-A1 | Tranexamic acid formulations | XANODYNE PHARMACEUTICALS, INC. (US) | 2008-11-13 | — | — | US | disclosed |
| US-20080189877-A1 | Mixture of quaternized imidazo[1,5-a]pyrimidinium derivate and benzaldehyde derivative; cationic hair dyes, oxidation color dyes; colorfastness, washfastness | HENKEL KGAA (DE) | 2008-08-14 | — | — | US | disclosed |
| US-7393367-B2 | Agent for dyeing keratin-based fibers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-07-01 | — | — | US | disclosed |
| US-20080104772-A1 | AGENT FOR DYEING KERATIN-BASED FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-05-08 | — | — | US | disclosed |
| US-20060127476-A1 | Delayed release oral dosage for side effect reduction of nausea, headache; improve patient compliance in treating menorrhagia; prevents a bolus release of tranexamic acid in the stomach | XANODYNE PHARMACEUTICALS, INC. (US) | 2006-06-15 | — | — | US | disclosed |
| WO-2006023001-A1 | TRANEXAMIC ACID FORMULATIONS | XANODYNE PHARMACEUTICALS, INC. (US) | 2006-03-02 | — | — | WO | disclosed |
| WO-2006023000-A1 | TRANEXAMIC ACID FORMULATIONS | XANODYNE PHARMACEUTICALS, INC. (US) | 2006-03-02 | — | — | WO | disclosed |
| US-20050244495-A1 | Adjusting release profile; urogenital disorders; blood disorders; edema | XANODYNE PHARMACEUTICALS, INC. (US) | 2005-11-03 | — | — | US | disclosed |
| US-20050245614-A1 | Oral administering; controlling blood concentration; urogenital disorders; blood disorders | XANODYNE PHARMACEUTICALS, INC. (US) | 2005-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080104772-A1 | AGENT FOR DYEING KERATIN-BASED FIBERS | KRT18, KAT5, H1-5 | GAA 4691/4885HSD17B10 466/4885KMT2A 2567/4885 |
| US-20080189877-A1 | Mixture of quaternized imidazo[1,5-a]pyrimidinium derivate and benzaldehyde derivative; cationic hair dyes, oxidation color dyes; colorfastness, washfastness | TYR, NDUFS5, WASHC5 | GAA 3840/4885HSD17B10 2529/4885KMT2A 1502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.